AzTrials
AzTrials

FrailtyELDERPLAYNCT07864831

Community-Based Multicomponent Exercise and Recreational Programme for Older Adults

A study testing ELDERPLAY multicomponent exercise and recreational programme in people with Frailty and Aging, run by Universidad de Murcia at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This quasi-experimental, non-randomized controlled evaluation examined whether participation in ELDERPLAY, a community-based programme combining Vivifrail-based multicomponent exercise with adapted traditional games, was associated with changes in physical performance and frailty-related function in community-dwelling… Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
Conditions the study is for
Frailty, Aging, Physical Functional Performance
What is being tested?
ELDERPLAY multicomponent exercise and recreational programme
Could I receive a placebo?
No, everyone receives an active treatment
How many people
184 participants
Where
1 siteSpain
Study dates
1 Jul 2022to 31 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Individuals aged 65 years or older, of both sexes.
  • Absence of cognitive deterioration or mild cognitive deterioration, as measured through the Pfeiffer Questionnaire (Pfeiffer score > 7 points).
  • Conserved mobility: absence of incapacitating illnesses that impeded walking with or without support devices, such as a cane. The use of a walking aid such as a cane was not in itself an exclusion criterion; participants who walked with a cane were eligible.

Who cannot join

  • Institutionalization in a nursing home.
  • Regular participation in structured physical exercise outside the study programme (i.e., attending supervised exercise sessions more than twice a week).

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Community facilities of the Municipality of Lorca

    Lorca, Murcia, 30800

Other trials in Spain

About this study

Official title: Physical Performance Outcomes and Programme Delivery Costs of ELDERPLAY, a Community-Based Multicomponent Exercise and Recreational Intervention for Older Adults: A Non-Randomized Controlled Evaluation

This quasi-experimental, non-randomized controlled evaluation examined whether participation in ELDERPLAY, a community-based programme combining Vivifrail-based multicomponent exercise with adapted traditional games, was associated with changes in physical performance and frailty-related function in community-dwelling adults aged 65 years and older, and estimated the cost of delivering the programme.

Participants were allocated to the intervention group or to a concurrent control group through voluntary enrolment and geographic matching, without randomization. The intervention consisted of 20 supervised group sessions, two per week over ten weeks. Physical performance was assessed with the Short Physical Performance Battery and the Timed Up and Go test at baseline, at week 5 and at week 10. Secondary exploratory outcomes included actigraphy-derived daily step count, heart rate and sleep parameters, recorded over seven consecutive days at a single intermediate assessment point, and sleep quality assessed with the Pittsburgh Sleep Quality Index.

Programme delivery costs were estimated from the perspective of the programme provider using an activity-based costing approach. Because allocation was not randomized and the groups differed at baseline, the findings are associative and do not support causal inference.

Read the detailed description

Recruitment was carried out in collaboration with community organizations and a federation of neighbourhood associations in the municipality of Lorca (Region of Murcia, Spain), between July 2022 and December 2023. Allocation was based on voluntary enrolment and on the geographic area of residence, with both groups recruited concurrently. Outcome assessment was not blinded to group allocation: all assessments were administered by a single assessor who was also responsible for delivering the intervention.

Statistical analysis used two-way analyses of covariance for the quantitative outcomes and generalized estimating equations for the dichotomous balance items, adjusted for the baseline variables that differed significantly between groups (cholesterol, COVID-19 vaccination and Barthel Index score).

Being tested
ELDERPLAY multicomponent exercise and recreational programme
Keywords
older adults, multicomponent exercise, traditional games, community-based programme, frailty prevention, Short Physical Performance Battery, Timed Up and Go, physical performance, programme costs
Medical subject headings
Frailty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ELDERPLAY multicomponent exercise and recreational programmeBehavioural

    Multicomponent exercise based on the Vivifrail programme (strength, balance, gait and flexibility training) combined with adapted traditional games, delivered in supervised group sessions of approximately 60 minutes, twice weekly for ten weeks, in community facilities.

Study groups in NCT07864831
Study groupRoleWhat they receive
ELDERPLAY programmeExperimentalTwenty supervised group sessions, two per week over ten weeks, combining Vivifrail-based multicomponent exercise (strength, balance, gait and flexibility) with traditional games adapted to the functional level of the participants.
Receives: Behavioral: ELDERPLAY multicomponent exercise and recreational programme
ControlNo interventionUsual daily activities. No structured exercise programme was provided by the study

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Short Physical Performance Battery (SPPB) total score

    Total score of the Short Physical Performance Battery, ranging from 0 to 12 points, combining the balance, gait and chair-stand components. Higher scores indicate better lower-extremity physical performance.

    Measured: Baseline (T0), week 5 (T1) and week 10 (T2)

  2. SPPB balance component

    Ability to hold the feet-together, semi-tandem and tandem stands, assessed as part of the Short Physical Performance Battery.

    Measured: Baseline (T0), week 5 (T1) and week 10 (T2)

  3. SPPB gait performance

    Time in seconds to walk 4 metres at usual pace, assessed as part of the Short Physical Performance Battery. Shorter times indicate better performance.

    Measured: Baseline (T0), week 5 (T1) and week 10 (T2)

  4. SPPB chair-stand performance

    Time in seconds to complete five sit-to-stand repetitions from a chair without using the arms, assessed as part of the Short Physical Performance Battery. Shorter times indicate better performance.

    Measured: Baseline (T0), week 5 (T1) and week 10 (T2)

  5. Timed Up and Go test

    Time in seconds to rise from a chair, walk 3 metres, turn, walk back and sit down again. Shorter times indicate better functional mobility.

    Measured: Baseline (T0), week 5 (T1) and week 10 (T2)

Secondary outcomes (5)
  1. Daily step count

    Mean number of steps per day derived from wrist-worn actigraphy over seven consecutive days.

    Measured: Week 5 (T1), over seven consecutive days

  2. Heart rate parameters

    Mean, maximum and minimum heart rate in beats per minute derived from wrist-worn actigraphy over seven consecutive days.

    Measured: Week 5 (T1), over seven consecutive days

  3. Actigraphy-derived sleep parameters

    Total sleep time and time in light, deep and REM sleep, and nap time, in minutes, derived from wrist-worn actigraphy over seven consecutive days. These measures are exploratory: consumer-grade wrist-worn devices show limited agreement with polysomnography for sleep-stage classification.

    Measured: Week 5 (T1), over seven consecutive days

  4. Sleep quality (Pittsburgh Sleep Quality Index)

    Global score of the Pittsburgh Sleep Quality Index, ranging from 0 to 21 points. Scores above 5 indicate poor sleep quality.

    Measured: Week 5 (T1)

  5. Programme delivery cost per participant

    Direct cost of delivering the programme per participant, in 2023 euros, estimated using an activity-based costing approach from the perspective of the programme provider, including personnel, transport, facility rental, wearable devices and consumables.

    Measured: Through programme completion, 10 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Oct 2026
  2. Study start1 Jul 2022
  3. Primary completion31 Dec 2023
  4. Study completion31 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Two parallel groups recruited concurrently; allocation to the intervention or control group was determined by voluntary enrolment and by the participant's geographic area of residence, without randomization.
Masking
None (open label)
Enrolment
184 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07864831
Sponsor's protocol ID
ELDERPLAY-UMU-3992-2022
Other IDs
3992/2022, CEI-2022-04-20
Acronym
ELDERPLAY
Status last verified
Oct 2026
First submitted
2 Oct 2026
Last updated
8 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data underlying the results reported in this study, including physical performance measures (Short Physical Performance Battery and Timed Up and Go), actigraphy-derived variables and baseline sociodemographic and clinical characteristics, are available on reasonable request from the corresponding author. Access is subject to privacy restrictions concerning participant confidentiality.

Questions about this trial

What is this clinical trial studying?

A study testing ELDERPLAY multicomponent exercise and recreational programme in people with Frailty and Aging, run by Universidad de Murcia at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Short Physical Performance Battery (SPPB) total score (time frame: Baseline (T0), week 5 (T1) and week 10 (T2)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in